LOC107987407: A Potential Drug Target and Biomarker (G107987407)
LOC107987407: A Potential Drug Target and Biomarker
LOC107987407 is a novel protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function make it an intriguing candidate for further research and development as a new drug or diagnostic agent.
The protein LOC107987407 is a member of the protein kinase C (PKC) family, which is a well-established family of intracellular signaling proteins that play a crucial role in a variety of cellular processes, including cell survival, proliferation, and angiogenesis. PKC signaling is involved in many cellular processes, including the regulation of cell adhesion, migration, and differentiation.
LOC107987407 is a 21-kDa protein that is expressed in a variety of tissues and cells, including brain, heart, liver, and muscle. It is highly conserved, with a calculated pI of 6.5 and a predicted localization in the cytoplasm. LOC107987407 is composed of a unique combination of amino acids, including a thioredoxin-rich region, a catalytic domain, and a carboxy-terminal region.
The thioredoxin-rich region is a conserved region that is involved in the regulation of cellular processes, including DNA replication, metabolism, and stress response. The catalytic domain is a key region that is involved in protein-protein interactions and is known to be involved in the regulation of cellular signaling pathways. The carboxy-terminal region is involved in the formation of LOC107987407's unique structure and function.
LOC107987407 has been shown to play a role in several cellular processes, including the regulation of cell adhesion, migration, and differentiation. For example, LOC107987407 has been shown to be involved in the regulation of brain endothelial cell (BEC) formation and function. BECs are specialized cells that form the blood-brain barrier and play a crucial role in maintaining the brain's integrity and protecting it from external factors.
LOC107987407 has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-established signaling pathway that is involved in the regulation of cellular processes, including cell growth, differentiation, and stress response. LOC107987407 has been shown to play a role in the regulation of TGF-β signaling by interacting with its downstream effector, p16INK4a.
In addition to its role in cellular signaling pathways, LOC107987407 has also been shown to be involved in the regulation of cellular processes, including cell adhesion and migration. For example, LOC107987407 has been shown to be involved in the regulation of cell adhesion by interacting with the adhesion molecule E-cadherin.
LOC107987407 has also been shown to be involved in the regulation of cellular processes, including cell cycle progression and apoptosis. For example, LOC107987407 has also been shown to play a role in the regulation of cell cycle progression by interacting with the protein p21.
In conclusion, LOC107987407 is a novel protein that has been identified as a potential drug target and biomarker for several diseases. Its unique structure and function make it an intriguing candidate for further research and development as a new drug or diagnostic agent. Further studies are needed to determine the full extent of LOC107987407's involvement in cellular processes and its potential as a drug target
Protein Name: Uncharacterized LOC107987407
The "LOC107987407 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107987407 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160
